Cargando…
Microbiome and bile acid profiles in duodenal aspirates from patients with liver cirrhosis: The Microbiome, Microbial Markers and Liver Disease Study
AIM: Cirrhosis is a leading cause of death worldwide, yet there are no well‐established risk stratifying tools for lethal complications, including hepatocellular carcinoma (HCC). Patients with liver cirrhosis undergo routine endoscopic surveillance, providing ready access to duodenal aspirate sample...
Autores principales: | Jacobs, Jonathan P., Dong, Tien S., Agopian, Vatche, Lagishetty, Venu, Sundaram, Vinay, Noureddin, Mazen, Ayoub, Walid S., Durazo, Francisco, Benhammou, Jihane, Enayati, Pedram, Elashoff, David, Goodman, Marc T., Pisegna, Joseph, Hussain, Shehnaz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334634/ https://www.ncbi.nlm.nih.gov/pubmed/29923681 http://dx.doi.org/10.1111/hepr.13207 |
Ejemplares similares
-
Duodenal Microbiome and Serum Metabolites Predict Hepatocellular Carcinoma in a Multicenter Cohort of Patients with Cirrhosis
por: Dong, Tien S., et al.
Publicado: (2021) -
Dietary Protein, Fiber and Coffee Are Associated with Small Intestine Microbiome Composition and Diversity in Patients with Liver Cirrhosis
por: Hussain, Shehnaz K., et al.
Publicado: (2020) -
Human liver single nucleus and single cell RNA sequencing identify a hepatocellular carcinoma-associated cell-type affecting survival
por: Alvarez, Marcus, et al.
Publicado: (2022) -
Gut microbiome profiles associated with steatosis severity in metabolic associated fatty liver disease
por: Dong, Tien S., et al.
Publicado: (2021) -
Routine Laboratory Blood Tests May Diagnose Significant Fibrosis in Liver Transplant Recipients with Chronic Hepatitis C: A 10 Year Experience
por: Sheen, Victoria, et al.
Publicado: (2016)